Liver Cirrhosis: all 1,668 studies

Page 4 of 17. Open to participants first (360), then studies with results posted, then the rest; newest registration first within each.

• Impact of Dietary Assessment and Intervention on Outcomes in Liver Cirrhosis PatientsRecruitingNCT05259930Not applicable
• Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)RecruitingNCT05224960Phase 2
• HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver DiseaseRecruitingNCT05205954Not applicable
• Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRecruitingNCT05201404Phase 3
• Multi-analyte Blood Test Clinical TrialRecruitingNCT05199259
• Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With CancerRecruitingNCT05181826
• HMB Enriched Amino Acids to Reverse Muscle Loss in CirrhosisRecruitingNCT05166499Not applicable
• Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B CirrhosisRecruitingNCT05106972Not applicable
• Instructed Home-based Physical Exercise for Patients With Liver CirrhosisRecruitingNCT05061576Not applicable
• Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMIRecruitingNCT05046483
• Safety and Efficacy of Atorvastatin v. Placebo on HCC RiskRecruitingNCT05028829Phase 2
• Characterization and Pathogenesis of ACLFRecruitingNCT04975490
• Efficacy of Simvastatin in Alcoholic Liver FibrosisRecruitingNCT04971577Phase 2/3
• Faecal Microbiota Transplantation for Liver CirrhosisRecruitingNCT04932577Phase 2/3
• Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver CirrhosisRecruitingNCT04874428Phase 1
• Danazol for Treatment of Cytopenias in Patients With CirrhosisRecruitingNCT04873102Phase 2
• Clinical Study of Hepatocyte Transplantation for Liver CirrhosisNot yet recruitingNCT04806581Phase 1
• TIPS in Patients With Decompensated Liver CirrhosisRecruitingNCT04801290
• Cirrhosis Registry of Hospitalized PatientsRecruitingNCT04767945
• Impact of Fentanyl Analgesia on the Accuracy of HVPG Measurements in Patients With Portal HypertensionRecruitingNCT04724148Not applicable
• Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic CirrhosisRecruitingNCT04689152Phase 3
• Integrated Diagnostics for Early Diagnosis of Liver DiseaseRecruitingNCT04666402
• HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.RecruitingNCT04640129Phase 4
• Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEsRecruitingNCT04613921
• Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in CirrhosisRecruitingNCT04588077Phase 4
• Predicting Acute-on-Chronic Liver Failure After Surgical Intervention in Chronic Liver DiseaseRecruitingNCT04578301
• FAST (Focused Abbreviated Screening Technique)-MRI StudyEnrolling by invitationNCT04539717
• Intraabdominal Hypertension and Occurrence of Microaspiration in Cirrhotics Under Mechanical VentilationRecruitingNCT04530760
• Comparison of Nutritional Screening Tools in Liver Cirrhosis PatientsRecruitingNCT04502719
• Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled TrialRecruitingNCT04448028Phase 4
• The European NAFLD RegistryRecruitingNCT04442334
• Rapid Breath-hold Quantitative Macromolecular Proton Fraction Imaging for Liver FibrosisRecruitingNCT04429100
• Periinterventional Coagulation Management of Patients Undergoing a TIPSRecruitingNCT04421924Not applicable
• Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular CarcinomaRecruitingNCT04414956Not applicable
• Prehabilitation and Posttransplant Training Program in Liver TransplantationEnrolling by invitationNCT04246970Not applicable
• Erlotinib for Hepatocellular Carcinoma ChemopreventionNot yet recruitingNCT04172779Phase 2
• Cirrhosis Care Alberta (CCAB): A Pragmatic Type II Hybrid Effectiveness Implementation TrialRecruitingNCT04149223Not applicable
• Antibiotic Prophylaxis in Patients Undergoing GVORecruitingNCT04140578Phase 4
• Ivabradine in Cirrhotic CardiomyopathyRecruitingNCT04111133Not applicable
• A Phase II Open-label Single-arm Study to Evaluate the Efficacy and Safety of ADSCs in Subjects With Liver CirrhosisRecruitingNCT04088058Phase 2
• Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and LactuloseRecruitingNCT04073290Phase 4
• Liver Damage and Cardiometabolic Disorders in NAFLDRecruitingNCT04036357
• Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPSRecruitingNCT03933891
• Study of microRNAs in a Decompensated CirrhosisRecruitingNCT03905746
• Liver Disease in PregnancyRecruitingNCT03834285
• Effect of Some Drugs on Liver FibrosisRecruitingNCT03770936Phase 3
• Non-Invasive Characterization of Focal Liver Lesions in Liver CirrhosisRecruitingNCT03746210
• Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and OutcomeRecruitingNCT03584204
• Screening With FibroTouch for Advanced Liver Fibrosis in NAFLD Patients With Underlying Type 2 DiabetesRecruitingNCT03525769
• Safety and Efficacy Study of Co-transfering of Mesenchymal Stem Cell and Regulatory T Cells in Treating End-stage Liver DiseaseNot yet recruitingNCT03460795Phase 1/2
• VICIS - Vienna Cirrhosis StudyRecruitingNCT03267615
• Volatiles in Breath and Headspace Analysis - Diagnostic MarkersEnrolling by invitationNCT03228095
• Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in CirrhosisRecruitingNCT03208868Not applicable
• Quantitative Diagnosis of Liver Fibrosis on Multiparametric MRIEnrolling by invitationNCT03176797Not applicable
• The Natural History and Prognostic Factors of Compensated Cirrhosis.RecruitingNCT03144700
• Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver CirrhosisNot yet recruitingNCT03130127Not applicable
• Microbiome and Sarcopenia in Patients With Liver CirrhosisRecruitingNCT03080129Not applicable
• Study of Orphenadrine' in the Treatment of Muscle Cramps in Patients With CirrhosisRecruitingNCT02423395Phase 3
• Cirrhosis, Effects of TRAnsplantation and DiabetesRecruitingNCT02038517
• Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft TissuesRecruitingNCT01757730
• A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.CompletedNCT06750276Phase 2Results posted
• Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver CirrhosisCompletedNCT06478602Phase 3Results posted
• A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCKCompletedNCT06269484Phase 2Results posted
• PK Profile and Preliminary Efficacy of TNP-2092 Capsules in Liver Cirrhosis Patients With HyperammonemiaCompletedNCT06135675Phase 1/2Results posted
• A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the BellyTerminatedNCT06082843Phase 2Results posted
• A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis PatientsCompletedNCT05928624Not applicableResults posted
• A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVCompletedNCT05904470Phase 2Results posted
• LiveSMART Trial to Prevent Falls in Patients With CirrhosisCompletedNCT05794555Phase 3Results posted
• A Study to Compare How Different Substances (Caffeine, Warfarin, Omeprazole, Metoprolol, and Midazolam) Are Handled by the Body of Healthy People and People With Liver CirrhosisCompletedNCT05741385Not applicableResults posted
• A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver CirrhosisCompletedNCT05741372Not applicableResults posted
• Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)TerminatedNCT05516498Phase 2Results posted
• A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisCompletedNCT05364931Phase 2Results posted
• Improving Pain Management and Opioid Safety for Patients With CirrhosisCompletedNCT05128578Not applicableResults posted
• A Trial to Improve Quality of Life in People With CirrhosisCompletedNCT05061992Phase 2/3Results posted
• Study in Healthy Adults Evaluating PF-07202954CompletedNCT04857437Phase 1Results posted
• Cirrhosis Medical HomeCompletedNCT04581369Not applicableResults posted
• A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 SubjectsCompletedNCT04480710Phase 2Results posted
• Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)CompletedNCT04321031Phase 2Results posted
• Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2)CompletedNCT04283994Not applicableResults posted
• Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1)CompletedNCT04281784Not applicableResults posted
• Prophylactic Antibiotics in Admitted CirrhoticsCompletedNCT04218695Phase 4Results posted
• Compare the Diuretic Effect With Furosemide vs Furosemide and Albumin Combined in Cirrhotic PatientsTerminatedNCT04216784Phase 4Results posted
• Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)CompletedNCT04210245Phase 2Results posted
• Using Data-Driven Implementation Strategies to Improve the Quality of Cirrhosis CareCompletedNCT04178096Not applicableResults posted
• Effect of Probiotics in Non-alcoholic Fatty Liver Disease and SteatohepatitisTerminatedNCT04175392Phase 1/2Results posted
• Efficacy and Safety of Anticoagulant Therapy in Portal Vein ThrombosisCompletedNCT04173429Phase 4Results posted
• A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)SuspendedNCT04104321Phase 3Results posted
• Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.TerminatedNCT04065841Phase 2Results posted
• Safety and Tolerability of Cilofexor in Participants With Primary Sclerosing Cholangitis (PSC) and Compensated CirrhosisTerminatedNCT04060147Phase 1Results posted
• Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver FibrosisTerminatedNCT04048876Phase 2Results posted
• The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and SteatosisCompletedNCT03957070Not applicableResults posted
• FMT in Cirrhosis and Hepatic EncephalopathyCompletedNCT03796598Phase 1/2Results posted
• Facilitating Communication StudyCompletedNCT03721952Not applicableResults posted
• MNK6106 for Liver Disease (Hepatic Cirrhosis) That in the Past Has Affected the Brain (Hepatic Encephalopathy)CompletedNCT03712280Phase 2Results posted
• An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With FibrosisCompletedNCT03656068Phase 2Results posted
• Liver Fibrosis Evaluation Using Ultrasound Shear Wave ImagingCompletedNCT03637959Not applicableResults posted
• Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic ImpairmentTerminatedNCT03633227Phase 4Results posted
• Mild Hypothermia and Acute Kidney Injury in Liver TransplantationTerminatedNCT03534141Not applicableResults posted
• Study of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver FibrosisCompletedNCT03517540Phase 2Results posted
• A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver CirrhosisCompletedNCT03486912Phase 2Results posted

← Liver Cirrhosis overview